Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
PhoreMost and POLARISqb Announce a Multi-target Collaboration to Investigate Next-generation Cancer Therapies
PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, and […]
PRISM BioLab Enters Multi-Project Drug Discovery Collaboration with Roche and Genentech
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery […]
Leiden Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine
Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against […]
New Triple Wrapped Culture Media Plates for Environmental Monitoring Provide Advanced Sterility Assurance to Pharmaceutical Manufacturers
Pharmaceutical manufacturers can now perform more confident, compliant environmental monitoring using culture media plates that […]
Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19
Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 […]
Alamar Biosciences Partners with Abcam to Drive Understanding of the Human Proteome
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the […]
Kyverna Therapeutics Announces Exclusive Worldwide Licenses With National Institutes of Health for Autologous and Allogeneic Anti-CD19 CAR T Cellular Therapies to Treat Autoimmune Diseases
Kyverna Therapeutics (“Kyverna”), a cell therapy company engineering a new class of therapies for autoimmune […]
Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Limited’s Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization […]
Testing Measures to Ensure Young People Return to Classrooms
All secondary schools have been asked to provide one on-site test for pupils ahead of […]
Onxeo Appoints Julien Miara as New Interim CEO
Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), (“Onxeo” or “the Company”), a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more